| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PLRZPolyrizon Ltd. | 16.19M | 15.54 | 31.08 | -5.21% | ||||
| TOVXTheriva Biologics, Inc. | 7.49M | 0.21 | -0.01 | -388.69% | 0.08 | |||
| CTXRCitius Pharmaceuticals, Inc. | 17.79M | 0.86 | -0.14 | -258.23% | -59.6% | 0.00 | ||
| ACXPAcurx Pharmaceuticals, Inc. | 6.32M | 2.69 | -0.15 | -0.25% | ||||
| ITRMIterum Therapeutics plc | 17.16M | 0.32 | -0.26 | -69.13% | ||||
| ANTXAN2 Therapeutics, Inc. | 34.25M | 1.25 | -0.73 | -56.29% | ||||
| MCRBSeres Therapeutics, Inc. | 137.33M | 15.18 | -0.80 | 15.37% | 12.34% | 6.65 | ||
| PYPDPolyPid Ltd. | 73.03M | 4.39 | -0.89 | -10.39% | 1.25 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 383.45K | 535.17K | 911.51K | 1.54M | 1.3M | 431.38K | 0 |
| Revenue Growth % | - | - | 0.4% | 0.7% | 0.69% | -0.16% | -0.67% | -1% |
| Cost of Goods Sold | 58.9K | 318.01K | 794.54K | 1.01M | 1.46M | 1.22M | 420.81K | 255.05K |
| COGS % of Revenue | - | 0.83% | 1.48% | 1.11% | 0.95% | 0.94% | 0.98% | - |
| Gross Profit | -58.9K | 65.44K | -259K | -104K | 81.85K | 80.06K | 10.57K | -255K |
| Gross Margin % | - | 0.17% | -0.48% | -0.11% | 0.05% | 0.06% | 0.02% | - |
| Gross Profit Growth % | - | 2.11% | -4.96% | 0.6% | 1.79% | -0.02% | -0.87% | -25.13% |
| Operating Expenses | 5.63M | 10.39M | -259K | 20.17M | 19.29M | 17.25M | 10.61M | 3.54M |
| OpEx % of Revenue | - | 27.11% | -0.48% | 22.13% | 12.51% | 13.31% | 24.6% | - |
| Selling, General & Admin | 2.88M | 6.73M | 10.78M | 7.71M | 8.03M | 7.97M | 4.42M | 1.47M |
| SG&A % of Revenue | - | 17.55% | 20.14% | 8.46% | 5.21% | 6.15% | 10.23% | - |
| Research & Development | 2.5M | 3.1M | 6.94M | 11.59M | 10.87M | 9.22M | 5.2M | 1.94M |
| R&D % of Revenue | - | 8.09% | 12.97% | 12.71% | 7.05% | 7.11% | 12.05% | - |
| Other Operating Expenses | 257K | -9.77M | -17.98M | 877K | 392K | 68.95K | 999K | 128K |
| Operating Income | -5.69M | -10.33M | -18.2M | -19.89M | -19.21M | -17.51M | -10.6M | -3.8M |
| Operating Margin % | - | -26.93% | -34% | -21.83% | -12.46% | -13.51% | -24.57% | - |
| Operating Income Growth % | - | -0.81% | -0.76% | -0.09% | 0.03% | 0.09% | 0.39% | 0.64% |
| EBITDA | -5.63M | -9.65M | -16.9M | -18.56M | -18.01M | -16.3M | -9.48M | -3.54M |
| EBITDA Margin % | - | -25.16% | -31.58% | -20.36% | -11.68% | -12.58% | -21.97% | - |
| EBITDA Growth % | - | -0.71% | -0.75% | -0.1% | 0.03% | 0.1% | 0.42% | 0.63% |
| D&A (Non-Cash Add-back) | 58.9K | 682.29K | 1.3M | 1.33M | 1.19M | 1.21M | 1.13M | 255.05K |
| EBIT | -2.56M | -10.68M | -16.42M | 5.16M | -27.02M | -11.53M | -10.6M | -4.01M |
| Net Interest Income | 0 | -4.46M | -3.7M | -244K | -93.6K | 146.59K | -121K | -147K |
| Interest Income | 44.27K | 0 | 0 | 0 | 0 | 146.59K | 0 | 0 |
| Interest Expense | 0 | 4.46M | 3.7M | 243.63K | 93.6K | 0 | 121.14K | 146.92K |
| Other Income/Expense | 3.13M | -4.81M | -1.92M | 0 | -7.91M | 5.98M | 6.26M | -361K |
| Pretax Income | -2.56M | -15.13M | -20.12M | 4.92M | -27.11M | -11.53M | -4.34M | -4.16M |
| Pretax Margin % | - | -39.47% | -37.59% | 5.4% | -17.58% | -8.89% | -10.06% | - |
| Income Tax | -14.05K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.99% | 0.98% | 0.93% | 1.44% | 0.92% | 0.85% | 0.65% | 1.03% |
| Net Income | -2.55M | -14.83M | -18.69M | 7.07M | -25.05M | -9.8M | -2.83M | -4.27M |
| Net Margin % | - | -38.68% | -34.92% | 7.75% | -16.24% | -7.56% | -6.55% | - |
| Net Income Growth % | - | -4.82% | -0.26% | 1.38% | -4.54% | 0.61% | 0.71% | -0.51% |
| Net Income (Continuing) | -2.56M | -15.13M | -20.12M | 4.92M | -27.11M | -11.53M | -4.34M | -4.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -14.04K | -368.53K | -1.51M | -3.68M | -6.1M | -7.88M | -9.46M | -9.36M |
| EPS (Diluted) | -0.85 | -5.31 | -6.40 | 2.00 | -7.15 | -2.75 | -0.62 | -0.78 |
| EPS Growth % | - | -5.25% | -0.21% | 1.31% | -4.58% | 0.62% | 0.77% | -0.26% |
| EPS (Basic) | -0.85 | -5.31 | -6.40 | 2.03 | -7.15 | -2.75 | -0.62 | -0.78 |
| Diluted Shares Outstanding | 3.01M | 2.79M | 2.9M | 3.15M | 3.5M | 3.57M | 4.52M | 5.45M |
| Basic Shares Outstanding | 3.01M | 2.79M | 2.9M | 3.11M | 3.5M | 3.57M | 4.52M | 5.45M |
| Dividend Payout Ratio | - | - | - | 0.11% | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 20.28M | 28.72M | 8.03M | 33.66M | 12.69M | 7.07M | 2.48M | 959.55K |
| Cash & Short-Term Investments | 18.22M | 13.02M | 6.25M | 31.88M | 8.5M | 1.99M | 2.01M | 874.24K |
| Cash Only | 16.25M | 12.01M | 5.19M | 3.5M | 8.13M | 1.88M | 2.01M | 874.24K |
| Short-Term Investments | 1.97M | 1.01M | 1.06M | 28.38M | 236.62K | 102.48K | 0 | 0 |
| Accounts Receivable | 179.49K | 990.85K | 487.59K | 341.06K | 3.56M | 1.18M | 70.94K | 4.54K |
| Days Sales Outstanding | - | 943.17 | 332.55 | 136.57 | 842.9 | 332.53 | 60.03 | - |
| Inventory | 1.54M | 30.64K | 34.19K | 39.13K | 35.77K | 27.72K | 0 | 0 |
| Days Inventory Outstanding | 9.52K | 35.17 | 15.7 | 14.07 | 8.94 | 8.32 | - | - |
| Other Current Assets | 99.58K | 14.22M | 309.03K | 135.95K | 71.2K | 3.34M | 0 | 0 |
| Total Non-Current Assets | 11.28M | 16.35M | 15.92M | 10.57M | 9.22M | 13.8M | 18.16M | 15.17M |
| Property, Plant & Equipment | 346.59K | 4.26M | 7.09M | 5.38M | 4.03M | 3.17M | 1.85M | 0 |
| Fixed Asset Turnover | - | 0.09x | 0.08x | 0.17x | 0.38x | 0.41x | 0.23x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.47M | 1.41M | 1.31M | 964.86K | 880.26K | 752.71K | 147.35K | 0 |
| Long-Term Investments | 7.39M | 7.09M | 7.11M | 4.08M | 4.16M | 9.74M | 16.1M | 15.1M |
| Other Non-Current Assets | 2.06M | 119.67K | 59.83K | 149.18K | 149.18K | 127.3K | 71.82K | 71.82K |
| Total Assets | 31.56M | 45.07M | 23.95M | 44.23M | 21.91M | 20.87M | 20.64M | 16.13M |
| Asset Turnover | - | 0.01x | 0.02x | 0.02x | 0.07x | 0.06x | 0.02x | - |
| Asset Growth % | - | 0.43% | -0.47% | 0.85% | -0.5% | -0.05% | -0.01% | -0.22% |
| Total Current Liabilities | 1.33M | 12.18M | 2.67M | 3.87M | 4.38M | 12.5M | 2.1M | 4.34M |
| Accounts Payable | 0 | 40.14K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | 46.07 | - | - | - | - | - | - |
| Short-Term Debt | 480K | 10.11M | 0 | 627.92K | 204.7K | 6.01M | 204.41K | 3.24M |
| Deferred Revenue (Current) | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 811.93K | 55.48K | -627.92K | -204.7K | 0 | -204.41K | 0 |
| Current Ratio | 15.24x | 2.36x | 3.00x | 8.70x | 2.90x | 0.57x | 1.18x | 0.22x |
| Quick Ratio | 14.09x | 2.35x | 2.99x | 8.69x | 2.89x | 0.56x | 1.18x | 0.22x |
| Cash Conversion Cycle | - | 932.27 | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 143.87K | 6.43M | 2.21M | 23.85K | 530.78K | 3.16M | 14.18K |
| Long-Term Debt | 0 | 0 | 6.33M | 2.01M | 0 | 500K | 3.06M | 0 |
| Capital Lease Obligations | 0 | 143.87K | 97.32K | 203.04K | 23.85K | 30.78K | 99.48K | 14.18K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.33M | 12.33M | 9.1M | 6.08M | 4.4M | 13.03M | 5.26M | 4.35M |
| Total Debt | 480K | 10.3M | 6.47M | 3.32M | 217.17K | 6.85M | 3.49M | 3.35M |
| Net Debt | -15.77M | -1.71M | 1.29M | -174.98K | -7.91M | 4.97M | 1.48M | 2.48M |
| Debt / Equity | 0.02x | 0.31x | 0.44x | 0.09x | 0.01x | 0.88x | 0.23x | 0.28x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -2.32x | -4.92x | -81.66x | -205.20x | - | -87.51x | -25.84x |
| Total Equity | 30.23M | 32.75M | 14.85M | 38.15M | 17.51M | 7.83M | 15.38M | 11.78M |
| Equity Growth % | - | 0.08% | -0.55% | 1.57% | -0.54% | -0.55% | 0.96% | -0.23% |
| Book Value per Share | 10.04 | 11.73 | 5.12 | 12.10 | 5.00 | 2.19 | 3.40 | 2.16 |
| Total Shareholders' Equity | 30.24M | 33.11M | 16.36M | 41.83M | 23.61M | 15.71M | 24.85M | 21.13M |
| Common Stock | 27.86M | 28.98M | 29.04M | 34.02M | 35.64M | 35.71M | 53 | 55 |
| Retained Earnings | -2.55M | -17.38M | -37.56M | -30.49M | -55.54M | -65.34M | -68.16M | -72.43M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -367.78K | -1.48M | -5.55K | 53.3K | -2.02K | 33.81K | -10.62K | 89.16K |
| Minority Interest | -14.04K | -368.53K | -1.51M | -3.68M | -6.1M | -7.88M | -9.46M | -9.36M |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -5.78M | -10.04M | -13.38M | -15.93M | -14.65M | -12.32M | -7.72M | -1.19M |
| Operating CF Margin % | - | -26.17% | -25.01% | -17.48% | -9.5% | -9.51% | -17.91% | - |
| Operating CF Growth % | - | -0.74% | -0.33% | -0.19% | 0.08% | 0.16% | 0.37% | 0.85% |
| Net Income | -2.55M | -15.13M | -20.12M | 4.92M | -27.11M | -11.53M | -4.34M | -4.27M |
| Depreciation & Amortization | 58.9K | 682.29K | 1.3M | 1.33M | 1.19M | 1.21M | 1.13M | 255.05K |
| Stock-Based Compensation | 0 | 0 | 1.61M | 1.48M | 1.68M | 1.65M | 1.27M | 0 |
| Deferred Taxes | 0 | 0 | -1.53M | -24.46M | 7.96M | 0 | 0 | 0 |
| Other Non-Cash Items | -2.93M | 4.81M | 4.14M | 751.03K | 609.34K | -5.05M | -6.18M | 3.03M |
| Working Capital Changes | -195.09K | -389.73K | 1.22M | 45.55K | 1.02M | 1.4M | 407.07K | -211.1K |
| Change in Receivables | -48.01K | -2.83K | -37.72K | -21.68K | -16.5K | -171.91K | 417.22K | 41.35K |
| Change in Inventory | 0 | -30.64K | -3.54K | -4.95K | 3.36K | 8.05K | 14.52K | 0 |
| Change in Payables | 0 | 58.55K | 986.24K | 800.96K | 855.27K | 1.92M | 398.63K | 0 |
| Cash from Investing | 12.8M | -6.06M | -108.06K | 1.84M | 16.51M | 2.44M | 624.77K | 58.62K |
| Capital Expenditures | -3.06M | -6.06M | -1.11M | -161.31K | -137.78K | -186.92K | -3.02K | 0 |
| CapEx % of Revenue | - | 15.82% | 2.07% | 0.18% | 0.09% | 0.14% | 0.01% | - |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -186.9K | 83.73K | -70.11K | 1.05M | -3.35M | 2.5M | 519.18K | 0 |
| Cash from Financing | 9.08M | 25.48M | -7.32M | 12.42M | 2.78M | 6.63M | 4.09M | 1.43K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | -755.51K | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 0 | -1.64M | 0 | 40.42K | 824.24K | 169.46K | -54.53K | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | -8.84M | -16.1M | -14.49M | -16.09M | -14.79M | -12.51M | -7.73M | -1.19M |
| FCF Margin % | - | -41.99% | -27.08% | -17.66% | -9.59% | -9.65% | -17.91% | - |
| FCF Growth % | - | -0.82% | 0.1% | -0.11% | 0.08% | 0.15% | 0.38% | 0.85% |
| FCF per Share | -2.94 | -5.77 | -4.99 | -5.10 | -4.22 | -3.50 | -1.71 | -0.22 |
| FCF Conversion (FCF/Net Income) | 2.27x | 0.68x | 0.72x | -2.25x | 0.58x | 1.26x | 2.73x | 0.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -8.43% | -47.1% | -78.52% | 26.67% | -90.01% | -77.35% | -24.34% | -31.43% |
| Return on Invested Capital (ROIC) | -29.52% | -34.05% | -57.87% | -55.15% | -60.57% | -117.26% | -53.59% | -18.29% |
| Gross Margin | - | 17.07% | -48.4% | -11.41% | 5.31% | 6.18% | 2.45% | - |
| Net Margin | - | -3868.04% | -3491.81% | 775.31% | -1624.38% | -756.17% | -654.88% | - |
| Debt / Equity | 0.02x | 0.31x | 0.44x | 0.09x | 0.01x | 0.88x | 0.23x | 0.28x |
| Interest Coverage | - | -2.32x | -4.92x | -81.66x | -205.20x | - | -87.51x | -25.84x |
| FCF Conversion | 2.27x | 0.68x | 0.72x | -2.25x | 0.58x | 1.26x | 2.73x | 0.28x |
| Revenue Growth | - | - | 39.57% | 70.32% | 69.17% | -15.95% | -66.71% | -100% |
Aptorum Group Limited (APM) reported $0.4M in revenue for fiscal year 2024.
Aptorum Group Limited (APM) saw revenue decline by 100.0% over the past year.
Aptorum Group Limited (APM) reported a net loss of $7.1M for fiscal year 2024.
Aptorum Group Limited (APM) has a return on equity (ROE) of -31.4%. Negative ROE indicates the company is unprofitable.
Aptorum Group Limited (APM) had negative free cash flow of $9.0M in fiscal year 2024, likely due to heavy capital investments.